Graham Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-45,449
Closed -$121K 1042
2022
Q1
$121K Buy
+45,449
New +$121K ﹤0.01% 848